4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3S)-

 化学構造式
114761-89-6
CAS番号.
114761-89-6
化学名:
别名:
英語名:
4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3S)-
英語别名:
(-)-Epitaxifolin;(2R,3S)-(-)-Epitaxifolin;4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3S)-
CBNumber:
CB58123304
化学式:
C15H12O7
分子量:
304.25
MOL File:
114761-89-6.mol

4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3S)- 物理性質

沸点 :
687.6±55.0 °C(Predicted)
比重(密度) :
1.702±0.06 g/cm3(Predicted)
酸解離定数(Pka):
7.39±0.60(Predicted)

安全性情報

4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3S)- 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3S)- 化学特性,用途語,生産方法

使用

cis-Dihydroquercetin is a derivative of Quercetin (Q509500, Dihydrate) which is a flavonoid with anticancer activity. Quercetin is a mitochondrial ATPase and phosphodiesterase inhibitor. Quercetin Inhibits PI3-kinase activity and slightly inhibits PIP kinase activity. Quercetin has antiproliferative effects on cancer cell lines, reduces cancer cell growth via type II estrogen receptors, and arrests human leukemic T cells in late G1 phase of the cell cycle.

4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3S)- 上流と下流の製品情報

原材料

準備製品


4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3S)- 生産企業

Global( 4)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Chengdu Biopurify Phytochemicals Ltd.
+8618080483897
sales@biopurify.com China 3777 58
Chengdu Biopurify Phytochemicals Ltd. +86-028-82633397 18982077548
cwb1@biopurify.cn China 2376 60
Energy Chemical 021-58432009 400-005-6266
marketing1@energy-chemical.com China 44843 58

  • 114761-89-6
  • 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3S)-
  • (-)-Epitaxifolin
  • (2R,3S)-(-)-Epitaxifolin
Copyright 2017 © ChemicalBook. All rights reserved